AWM
FLNA

Apollon Wealth Management’s Filana Therapeutics FLNA Stock Holding History

Apollon Wealth Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.5K Sell
18,895
-16,158
-46% -$23K ﹤0.01% 1565
2026
Q1 		$59.2K Sell
35,053
-4,485
-11% -$9.23K ﹤0.01% 1362
2025
Q4 		$78.3K Sell
39,538
-6,733
-15% -$21.6K ﹤0.01% 1269
2025
Q3 		$135K Buy
46,271
+3,342
+8% +$7.69K ﹤0.01% 1256
2025
Q2 		$77.7K Buy
42,929
+2,692
+7% +$4.79K ﹤0.01% 1230
2025
Q1 		$60.4K Buy
40,237
+9,288
+30% +$23.4K ﹤0.01% 1168
2024
Q4 		$73K Buy
+30,949
New +$544K ﹤0.01% 1148
2024
Q3 		– Sell
-11,406
Closed -$141K – 1166
2024
Q2 		$141K Sell
11,406
-156
-1% -$3.29K ﹤0.01% 1034
2024
Q1 		$235K Buy
11,562
+890
+8% +$20.5K 0.01% 970
2023
Q4 		$240K Buy
10,672
+71
+0.7% +$1.5K 0.01% 924
2023
Q3 		$176K Buy
10,601
+1,951
+23% +$38.7K 0.01% 844
2023
Q2 		$212K Sell
8,650
-1,218
-12% -$29.3K 0.01% 851
2023
Q1 		$238K Buy
9,868
+2,785
+39% +$77.2K 0.01% 745
2022
Q4 		$209K Sell
7,083
-117
-2% -$4.21K 0.01% 772
2022
Q3 		$301K Sell
7,200
-1,924
-21% -$52K 0.02% 600
2022
Q2 		$257K Buy
9,124
+78
+0.9% +$1.97K 0.02% 608
2022
Q1 		$336K Buy
9,046
+402
+5% +$17K 0.02% 558
2021
Q4 		$378K Buy
8,644
+275
+3% +$14.4K 0.03% 525
2021
Q3 		$520K Buy
8,369
+1,925
+30% +$161K 0.07% 260
2021
Q2 		$551K Buy
6,444
+381
+6% +$20.4K 0.1% 204
2021
Q1 		$273K Buy
+6,063
New +$238K 0.05% 283

Other funds holding FLNA

JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
SWA
SOA Wealth Advisors New York $595M AUM 25.98% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Apollon Wealth Management's FLNA Position: Q2 2026 in Review

Apollon Wealth Management reduced its Filana Therapeutics (FLNA) stake by 46% in Q2 2026, selling an estimated $23K and leaving 18,895 shares worth $22.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1565.

Apollon Wealth Management first reported a position in FLNA in Q1 2021 and has held it in 21 quarters since. The position peaked at $551K in Q2 2021. 13 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Apollon Wealth Management held 18,895 shares of Filana Therapeutics worth $22.5K as of Q2 2026.
  • Apollon Wealth Management sold 16,158 Filana Therapeutics shares in Q2 2026, an estimated $23K.
  • Filana Therapeutics made up ﹤0.01% of Apollon Wealth Management's portfolio in Q2 2026, its #1565 holding.
  • Apollon Wealth Management first reported a position in Filana Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • Apollon Wealth Management's Filana Therapeutics position peaked at $551K in Q2 2021.
  • 13 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.